Stay alert, beware of scamsters - know more

NSEBSE
NSEBSE
noteThere is a 15-minute delay in the prices. To check out the live prices, log in to your Ventura account or open one today.
1D
1W
1M
1Y
3Y
5Y
Max
Open822
High823.8
Low815.95
Prev. Close816.65
Avg. Traded Price818.55
Volume26,213

MARKET DEPTH

info2
Total bid201.00
Total ask0.00
OrdersQtyBid
3201816.65
000
000
000
000
AskQtyOrders
000
000
000
000
000

HIGH/LOW

info2
1d
1w
1m
3m
52w

LOW/HIGH

815.956 hours ago
823.8012 hours ago
arrow

LOWER/UPPER CIRCUITS

657.75
986.55
arrow
Medplus Health Services Ltd Stock performance
arrow

KEY OBSERVATIONS

info
positive
negative
neutral
noteAnnual Revenue,rose 12.6%, in the last year to ₹6,963.79 Cr. Its sector's average revenue growth for the last fiscal year was 19.48%.
noteAnnual Net Profit,rose 46.12% in the last year to ₹219.65 Cr. Its sector's average net profit growth for the last fiscal year was -20.74%.
notePrice to Earning Ratio,is 44.97, lower than its sector PE ratio of 64.93.
View more

LONG-TERM PRICE ANALYSIS

info
Stock return5Y CAGR : %
Net profit growth 5Y CAGR : %

About MedPlus Health Services Limited

MedPlus Health Services Limited, incorporated on November 30, 2006, is a leading organised retail pharmacy chain in India with an omnichannel model spanning neighbourhood stores and digital platforms. Its portfolio includes pharmaceuticals, wellness items, and FMCG such as OTC medicines, vitamins, medical devices, toiletries, baby care, soaps, detergents, and sanitizers. As of March 31, 2025, operations spanned 13 states and 1 union territory across 700 cities with 4,712 stores, supported by a cluster-based expansion strategy and technology-driven supply chain. The company reported revenue from operations of Rs 6,136.05 crore in FY 2024-25 and PAT of Rs 150.23 crore. MedPlus launched MedPlus-branded pharmaceutical products covering acute and chronic therapies, which reached GMV of H 14,025.52 million (reported as a share of pharmacy revenues) in FY 2024 on a GMV basis, aligning with its focus on quality and affordability. Optival Health Solutions Private Limited is identified as a material subsidiary; exports contribute 0% of turnover. Operations are national, with no international offices.

MedPlus Health Services Limited Business Segment

  • Primary revenue streams are retail trade services of pharmaceutical products and medical/orthopaedic goods, contributing 98.24% of turnover (NIC 47721). Diagnostic-imaging services contribute 1.76% of turnover (NIC 86905).

  • Geographic split disclosure: Exports constitute 0% of turnover; markets served are exclusively national across 14 states, with 0 international countries served.

MedPlus Health Services Limited Key Management

  • Gangadi Madhukar Reddy — Chairman, Managing Director and Chief Executive Officer.

  • Dr. Cherukupalli Bhaskar Reddy — Whole Time Director and COO.

  • Sujit Kumar Mahato — Chief Financial Officer.

  • Manoj Kumar Srivastava — Head – Corporate Secretarial, Company Secretary and Compliance Officer.

  • Subrahmanyam Sharma T. — Chief Technology Officer.

  • Kandasamy — Head of Supply Chain.

Latest Updates on MedPlus Health Services Limited

  • Opened 305 new stores during the year, reinforcing the cluster-led expansion and presence in Delhi-NCR.

  • Revenue from operations grew 9.09% to Rs 6,136.05 crore in FY 2024-25; EBITDA was Rs 535.72 crore; PAT increased to Rs 150.23 crore.

  • Expanded MedPlus-branded pharmaceutical products across acute and chronic therapies; private label pharma GMV reported at H 14,025.52 million, contributing 17.50% of pharmacy revenues on GMV basis and 11.58% on net reported revenues (FY 2024 reference).

  • Affirmed no penalties or strictures by stock exchanges or SEBI related to capital markets during the year; maintained compliance with corporate governance requirements.

  • Optival Health Solutions Private Limited continued as a material subsidiary; related-party transaction approval proposed for FY 2025-26 on an arm’s length basis.

personal

Grow your wealth with more research recommendations

+91

Frequently Asked Questions

No,Medplus Health Services Ltd has not declared any dividend over the past 5 years. The company paid a total dividend of N/A per share between FY2022 and FY2026, with the most recent dividend of ₹N/A per share. At the current market price of ₹818.10, the trailing dividend yield of Medplus Health Services Ltd stands at N/A%.

Medplus Health Services Ltd has delivered a -26.67% absolute return over the past 5 years, equivalent to a CAGR of -6.02% per annum. The stock was priced at ₹1,115.64 in Jul 2021 and has fallen to ₹818.10 as of 07 Jul 2026. An investment of ₹1,00,000 in Medplus Health Services Ltd five years ago would be worth ₹73,330.00 today.

The all-time high (ATH) for Medplus Health Services Ltd was ₹1,290.00, recorded on 20 Jan 2022. At the current price of ₹818.10, the stock is trading 36.58% below its all-time high. The all-time low recorded was ₹576.30 on 09 Nov 2022.

Medplus Health Services Ltd has delivered -4.46% return over the last 52 weeks. During this period, the stock hit a 52-week high of ₹1,022.20 on 21 May 2026 and a 52-week low of ₹732.00 on 03 Oct 2025. It is currently trading at ₹818.10 as of 07 Jul 2026.

The intraday low for Medplus Health Services Ltd on the NSE today was ₹815.60. The stock's 52-week low stands at ₹732.00, recorded on 03 Oct 2025. Today's low is 11.42% above the 52-week low, indicating the stock is trading well above its yearly lows.

For Q4 FY26, Medplus Health Services Ltd reported: Revenue (Net Sales): ₹2480.36 Cr - Up 11.23% year-on-year from ₹2230.01 Cr in Q3 FY26. Net Income (PAT): ₹166.72 Cr - Up 0.58% year-on-year from ₹165.76 Cr in Q3 FY26.

Medplus Health Services Ltd has delivered a return of -2.50% over the last 3 months. The stock was trading at ₹843.25 on 07 Apr 2026 and is currently at ₹818.10 as of 07 Jul 2026, reflecting a Loss of ₹25.15 per share over this period.

As of 07 Jul 2026, the share price of Medplus Health Services Ltd is ₹818.10 on the NSE and ₹818.00 on the BSE. The stock opened at ₹822.00, touched a high of ₹830.00 and a low of ₹815.60 during today's session.

Over the last 6 months, Medplus Health Services Ltd has given a return of -1.40%. The stock was priced at ₹833.80 on 07 Jan 2026 and has Fallen to ₹818.10 as of 07 Jul 2026, a change of ₹15.70 per share.

The intraday high for Medplus Health Services Ltd on the NSE today (07 Jul 2026) was ₹830.00. This compares to the 52-week high of ₹1,022.20 recorded on 21 May 2026. Today's high was -18.80% below the 52-week high.

+91
Offer Banner Trigger
Offer Banner

Open a FREE Demat Account

+91